561 results on '"Jackson, Michael L"'
Search Results
2. Undergraduate Education in a Research University: Scaling High Impact Practices at USC. Research & Occasional Paper Series: CSHE.1.2019
3. Relationship between Telework Experience and Presenteeism during COVID-19 Pandemic, United States, March-November 2020
4. Association Between Aluminum Exposure From Vaccines Before Age 24 Months and Persistent Asthma at Age 24 to 59 Months
5. Identifying long-term effects of SARS-CoV-2 and their association with social determinants of health in a cohort of over one million COVID-19 survivors
6. Time to Mobility Is Associated With Pulmonary Complications in Patients With Spine Fractures.
7. Incidence, clinical outcomes, and transmission dynamics of severe coronavirus disease 2019 in California and Washington : prospective cohort study
8. Interim Estimates of 2019–20 Seasonal Influenza Vaccine Effectiveness — United States, February 2020
9. Low-impact social distancing interventions to mitigate local epidemics of SARS-CoV-2
10. Interim Estimates of 2018–19 Seasonal Influenza Vaccine Effectiveness — United States, February 2019
11. Differences between Frequentist and Bayesian inference in routine surveillance for influenza vaccine effectiveness: a test-negative case-control study
12. Effects of Air Pollution and Other Environmental Exposures on Estimates of Severe Influenza Illness, Washington, USA
13. Paid Leave and Access to Telework as Work Attendance Determinants during Acute Respiratory Illness, United States, 2017-2018
14. Use of self-reported vaccination status can bias vaccine effectiveness estimates from test-negative studies
15. Influence of Birth Cohort on Effectiveness of 2015–2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States
16. Influenza Antiviral Prescribing for Outpatients With an Acute Respiratory Illness and at High Risk for Influenza-Associated Complications During 5 Influenza Seasons—United States, 2011–2016
17. Interim Estimates of 2017–18 Seasonal Influenza Vaccine Effectiveness — United States, February 2018
18. Assessment of Tdap Vaccination Effectiveness in Adolescents in Integrated Health-Care Systems
19. Influenza vaccine effectiveness in older adults compared with younger adults over five seasons
20. The impact of selection bias on vaccine effectiveness estimates from test-negative studies
21. Burden of medically attended influenza infection and cases averted by vaccination – United States, 2013/14 through 2015/16 influenza seasons
22. Patterns of childhood immunization and all-cause mortality
23. The Burden of Community-Acquired Pneumonia in Seniors: Results of a Population-Based Study
24. Prior-Season Vaccination and Risk of Influenza During the 2014–2015 Season in the United States
25. Announcing the Publication of a WHO Guide to the Design and Interpretation of Observational Influenza Vaccine Effectiveness Studies
26. Intraseason Waning of Influenza Vaccine Protection: Evidence From the US Influenza Vaccine Effectiveness Network, 2011–2012 Through 2014–2015
27. Interim Estimates of 2016–17 Seasonal Influenza Vaccine Effectiveness — United States, February 2017
28. 2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type
29. Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015
30. First Trimester Influenza Vaccination and Risks for Major Structural Birth Defects in Offspring
31. Maternal Tdap vaccination and risk of infant morbidity
32. Assessing misclassification of vaccination status: Implications for studies of the safety of the childhood immunization schedule
33. Acute respiratory infections among individuals seeking outpatient care in the states of Washington and Michigan by pregnancy status, 2011–2016.
34. Reflections on a Life and Career in Student Affairs: Guideposts and Structure
35. Order of Live and Inactivated Vaccines and Risk of Non–vaccine-targeted Infections in US Children 11–23 Months of Age
36. White Paper on studying the safety of the childhood immunization schedule in the Vaccine Safety Datalink
37. Maternal Tdap vaccination: Coverage and acute safety outcomes in the vaccine safety datalink, 2007–2013
38. Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013–2014 in the United States
39. Illness Severity and Work Productivity Loss Among Working Adults With Medically Attended Acute Respiratory Illnesses: US Influenza Vaccine Effectiveness Network 2012–2013
40. Cumulative and episodic vaccine aluminum exposure in a population-based cohort of young children
41. Incidence of medically attended influenza infection and cases averted by vaccination, 2011/2012 and 2012/2013 influenza seasons
42. Effects of imperfect test sensitivity and specificity on observational studies of influenza vaccine effectiveness
43. Childhood vaccines and Kawasaki disease, Vaccine Safety Datalink, 1996-2006
44. Use of Influenza Antiviral Medications Among Outpatients at High Risk for Influenza-Associated Complications During the 2013–2014 Influenza Season
45. Influenza Vaccine Effectiveness in the United States During 2012-2013: Variable Protection by Age and Virus Type
46. Early Estimates of Seasonal Influenza Vaccine Effectiveness — United States, January 2015
47. Risk of Spontaneous Abortion After Inadvertent Human Papillomavirus Vaccination in Pregnancy
48. Association Between Estimated Cumulative Vaccine Antigen Exposure Through the First 23 Months of Life and Non–Vaccine-Targeted Infections From 24 Through 47 Months of Age
49. The safety of live attenuated influenza vaccine in children and adolescents 2 through 17 years of age: A Vaccine Safety Datalink study
50. Interim Estimates of 2013–14 Seasonal Influenza Vaccine Effectiveness — United States, February 2014
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.